![Sean MacDonald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sean MacDonald
Direktor/Vorstandsmitglied bei
EDESA BIOTECH, INC.
Vermögen: 14 823 $ am 31.05.2026
Profil
Sean A. MacDonald is Chief Executive Officer & Director at Kainova Therapeutics, Inc. Mr. MacDonald is Director-Sales & Licensing at Bioneer A. Mr. MacDonald is Independent Director at Edesa Biotech, Inc. since 2023.
Former roles include Chief Executive Officer at Corbin Therapeutics, Inc. from 2018 to 2021, Director-Business Development at Ablynx NV, Director at Edesa Biotech, Inc. (Old), Director at Edesa Biotech Research, Inc. from 2017 to 2019, Vice President-Business Development at Pharmascience, Inc. from 2012 to 2018, Head-Business Development at Cosmo Pharmaceuticals NV from 2019 to 2021, and Chief Business Officer at iOnctura SA from 2021 to 2022.
Education includes undergraduate and MBA degrees from the University of Ottawa.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EDESA BIOTECH, INC. 0.02% | 27.05.2026 | 2’053 ( 0.02% ) | 14 823 $ | 31.05.2026 |
Aktive Positionen von Sean MacDonald
| Unternehmen | Position | Beginn |
|---|---|---|
| EDESA BIOTECH, INC. | Direktor/Vorstandsmitglied | 01.05.2023 |
Bioneer A/S
 Bioneer A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Vertrieb & Marketing | - |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Sean MacDonald
| Unternehmen | Position | Ende |
|---|---|---|
iOnctura SA
 iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Corporate Officer/Principal | 01.04.2022 |
Corbin Therapeutics, Inc.
 Corbin Therapeutics, Inc. Internet Software/ServicesTechnology Services Operates as a biotechnology platform | Vorstandsvorsitzender | 01.08.2021 |
| COSMO N.V. | Corporate Officer/Principal | 01.08.2021 |
Edesa Biotech Research, Inc. | Direktor/Vorstandsmitglied | 01.06.2019 |
Pharmascience, Inc.
 Pharmascience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic and drug products | Corporate Officer/Principal | 01.10.2018 |
Ausbildung von Sean MacDonald
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
22
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
University of Ottawa
 University of Ottawa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Bioneer A/S
Bioneer A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products | Health Technology |
Pharmascience, Inc.
Pharmascience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic and drug products | Health Technology |
Cosmo Pharmaceuticals NV
 Cosmo Pharmaceuticals NV Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for gastrointestinal diseases and dermatology | Health Technology |
iOnctura SA
iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Health Technology |
Edesa Biotech, Inc. (Old)
 Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Develops novel non-steroidal molecules for the treatment of allergic contact dermatitis | Health Technology |
Edesa Biotech, Inc.
 Edesa Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of chronic allergic contact dermatitis | Health Technology |
Corbin Therapeutics, Inc.
Corbin Therapeutics, Inc. Internet Software/ServicesTechnology Services Operates as a biotechnology platform | Technology Services |
Edesa Biotech Research, Inc. |
